A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Huang, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcmaster University (data Collection Only)
Hamilton, Ontario, Canada
- University Health Network
Toronto, Ontario, Canada
- Centre Hospitalier de L'Université de Montreal
Montreal, Quebec, Canada
- University of California San Diego
San Diego, California, United States
- Stanford University Medical Center (data Collection Only)
Stanford, California, United States
- Hartford Healthcare
Hartford, Connecticut, United States
- Rush University Medical Center (data Collection Only)
Chicago, Illinois, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- George Washington University School of Medicine
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
- Roswell Park Cancer Institute (data Collection Only)
Buffalo, New York, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- New York Presbyterian Hospital
New York, New York, United States
- Memorial Sloan Kettering Nassau
Uniondale, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Lehigh Valley Health Network
Allentown, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Temple University
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- University of Pennsylvania (data Collection Only)
Philadelphia, Pennsylvania, United States
- Allegheny Health Network
Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Baylor University Medical Center
Houston, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jan 2019
- Primary completion
- 31 Jan 2027
- Completion
- 31 Jan 2027
- Last update posted
- 18 Feb 2026
- Registered enrollment
- 338
- Registry id
- NCT03802981
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.